Position in BMY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,366,804
-$238,662 QoQ
Shares Held
23,721
-10.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#998
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pekin Hardy Strauss, Inc. holds $25,845,902 across 12 Drug Manufacturers - General names. BMY ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,681 | $7,217,286 | |
| 2 | NVS |
Novartis AG
|
26,136 | $4,096,033 | |
| 3 | JNJ |
Johnson & Johnson
|
13,995 | $3,554,310 | |
| 4 | NVO |
Novo Nordisk A S
|
70,160 | $3,363,470 | |
| 5 | MRK |
Merck & Co., Inc.
|
24,621 | $3,163,798 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
23,721 | $1,366,804 | |
| 7 | LLY |
ELI LILLY & Co
|
971 | $1,164,646 | |
| 8 | AZN |
Astrazeneca PLC
|
3,262 | $618,540 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,366,804 | 23,721 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,605,466 | 26,471 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,361,068 | 25,233 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,413,298 | 31,337 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,433,230 | 30,962 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,855,437 | 30,422 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,721,799 | 30,442 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,529,020 | 29,552 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,077,786 | 25,952 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,856,075 | 34,226 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,708,982 | 33,307 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,582,170 | 61,719 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,247,495 | 66,419 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,584,440 | 66,144 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $4,765,248 | 66,230 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,812,508 | 67,696 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,148,682 | 66,866 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $4,798,144 | 65,701 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,883,220 | 62,281 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,652,978 | 61,737 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,219,855 | 48,187 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,965,531 | 46,975 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,900,088 | 46,753 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,087,209 | 51,206 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,063,832 | 52,106 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,554,619 | 45,831 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||